These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 16339572

  • 1. Complement-dependent apoptosis and inflammatory gene changes in murine lupus cerebritis.
    Alexander JJ, Jacob A, Bao L, Macdonald RL, Quigg RJ.
    J Immunol; 2005 Dec 15; 175(12):8312-9. PubMed ID: 16339572
    [Abstract] [Full Text] [Related]

  • 2. Administration of the soluble complement inhibitor, Crry-Ig, reduces inflammation and aquaporin 4 expression in lupus cerebritis.
    Alexander JJ, Bao L, Jacob A, Kraus DM, Holers VM, Quigg RJ.
    Biochim Biophys Acta; 2003 Nov 20; 1639(3):169-76. PubMed ID: 14636948
    [Abstract] [Full Text] [Related]

  • 3. Absence of functional alternative complement pathway alleviates lupus cerebritis.
    Alexander JJ, Jacob A, Vezina P, Sekine H, Gilkeson GS, Quigg RJ.
    Eur J Immunol; 2007 Jun 20; 37(6):1691-701. PubMed ID: 17523212
    [Abstract] [Full Text] [Related]

  • 4. Excessive matrix accumulation in the kidneys of MRL/lpr lupus mice is dependent on complement activation.
    Bao L, Zhou J, Holers VM, Quigg RJ.
    J Am Soc Nephrol; 2003 Oct 20; 14(10):2516-25. PubMed ID: 14514729
    [Abstract] [Full Text] [Related]

  • 5. Administration of a soluble recombinant complement C3 inhibitor protects against renal disease in MRL/lpr mice.
    Bao L, Haas M, Kraus DM, Hack BK, Rakstang JK, Holers VM, Quigg RJ.
    J Am Soc Nephrol; 2003 Mar 20; 14(3):670-9. PubMed ID: 12595503
    [Abstract] [Full Text] [Related]

  • 6. Low-dose targeted complement inhibition protects against renal disease and other manifestations of autoimmune disease in MRL/lpr mice.
    Atkinson C, Qiao F, Song H, Gilkeson GS, Tomlinson S.
    J Immunol; 2008 Jan 15; 180(2):1231-8. PubMed ID: 18178863
    [Abstract] [Full Text] [Related]

  • 7. C3aR inhibition reduces neurodegeneration in experimental lupus.
    Jacob A, Bao L, Brorson J, Quigg RJ, Alexander JJ.
    Lupus; 2010 Jan 15; 19(1):73-82. PubMed ID: 19900981
    [Abstract] [Full Text] [Related]

  • 8. Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice.
    Bao L, Haas M, Boackle SA, Kraus DM, Cunningham PN, Park P, Alexander JJ, Anderson RK, Culhane K, Holers VM, Quigg RJ.
    J Immunol; 2002 Apr 01; 168(7):3601-7. PubMed ID: 11907125
    [Abstract] [Full Text] [Related]

  • 9. Complement component C3 is not required for full expression of immune complex glomerulonephritis in MRL/lpr mice.
    Sekine H, Reilly CM, Molano ID, Garnier G, Circolo A, Ruiz P, Holers VM, Boackle SA, Gilkeson GS.
    J Immunol; 2001 May 15; 166(10):6444-51. PubMed ID: 11342671
    [Abstract] [Full Text] [Related]

  • 10. TNF-like weak inducer of apoptosis promotes blood brain barrier disruption and increases neuronal cell death in MRL/lpr mice.
    Wen J, Doerner J, Weidenheim K, Xia Y, Stock A, Michaelson JS, Baruch K, Deczkowska A, Gulinello M, Schwartz M, Burkly LC, Putterman C.
    J Autoimmun; 2015 Jun 15; 60():40-50. PubMed ID: 25911200
    [Abstract] [Full Text] [Related]

  • 11. Unrestricted C3 activation occurs in Crry-deficient kidneys and rapidly leads to chronic renal failure.
    Bao L, Wang Y, Chang A, Minto AW, Zhou J, Kang H, Haas M, Quigg RJ.
    J Am Soc Nephrol; 2007 Mar 15; 18(3):811-22. PubMed ID: 17229915
    [Abstract] [Full Text] [Related]

  • 12. Modulation of renal disease in MRL/lpr mice genetically deficient in the alternative complement pathway factor B.
    Watanabe H, Garnier G, Circolo A, Wetsel RA, Ruiz P, Holers VM, Boackle SA, Colten HR, Gilkeson GS.
    J Immunol; 2000 Jan 15; 164(2):786-94. PubMed ID: 10623824
    [Abstract] [Full Text] [Related]

  • 13. Nephritogenic anti-DNA antibodies regulate gene expression in MRL/lpr mouse glomerular mesangial cells.
    Qing X, Zavadil J, Crosby MB, Hogarth MP, Hahn BH, Mohan C, Gilkeson GS, Bottinger EP, Putterman C.
    Arthritis Rheum; 2006 Jul 15; 54(7):2198-210. PubMed ID: 16804897
    [Abstract] [Full Text] [Related]

  • 14. Negative role of colony-stimulating factor-1 in macrophage, T cell, and B cell mediated autoimmune disease in MRL-Fas(lpr) mice.
    Lenda DM, Stanley ER, Kelley VR.
    J Immunol; 2004 Oct 01; 173(7):4744-54. PubMed ID: 15383612
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological complement inhibition at the C3 convertase level promotes neuronal survival, neuroprotective intracerebral gene expression, and neurological outcome after traumatic brain injury.
    Leinhase I, Schmidt OI, Thurman JM, Hossini AM, Rozanski M, Taha ME, Scheffler A, John T, Smith WR, Holers VM, Stahel PF.
    Exp Neurol; 2006 Jun 01; 199(2):454-64. PubMed ID: 16545803
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of C5a receptor alleviates experimental CNS lupus.
    Jacob A, Hack B, Bai T, Brorson JR, Quigg RJ, Alexander JJ.
    J Neuroimmunol; 2010 Apr 15; 221(1-2):46-52. PubMed ID: 20207017
    [Abstract] [Full Text] [Related]

  • 17. Transgenic mice overexpressing the complement inhibitor crry as a soluble protein are protected from antibody-induced glomerular injury.
    Quigg RJ, He C, Lim A, Berthiaume D, Alexander JJ, Kraus D, Holers VM.
    J Exp Med; 1998 Oct 05; 188(7):1321-31. PubMed ID: 9763611
    [Abstract] [Full Text] [Related]

  • 18. Effects of complement factor D deficiency on the renal disease of MRL/lpr mice.
    Elliott MK, Jarmi T, Ruiz P, Xu Y, Holers VM, Gilkeson GS.
    Kidney Int; 2004 Jan 05; 65(1):129-38. PubMed ID: 14675043
    [Abstract] [Full Text] [Related]

  • 19. A complement C3 inhibitor specifically targeted to sites of complement activation effectively ameliorates collagen-induced arthritis in DBA/1J mice.
    Song H, Qiao F, Atkinson C, Holers VM, Tomlinson S.
    J Immunol; 2007 Dec 01; 179(11):7860-7. PubMed ID: 18025232
    [Abstract] [Full Text] [Related]

  • 20. Decay-accelerating factor ameliorates systemic autoimmune disease in MRL/lpr mice via both complement-dependent and -independent mechanisms.
    Miwa T, Maldonado MA, Zhou L, Yamada K, Gilkeson GS, Eisenberg RA, Song WC.
    Am J Pathol; 2007 Apr 01; 170(4):1258-66. PubMed ID: 17392165
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.